Latest filing published 11 Jan 2021 for China Regenerative Medicine International Ltd..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -58.2%Entry HK$6.70 · Close at T+365 HK$2.80
- +100.0%Entry HK$2.70 · Close at T+365 HK$5.40
- +112.0%Entry HK$2.50 · Close at T+365 HK$5.30
- +106.5%Entry HK$2.47 · Close at T+365 HK$5.10
- +104.0%Entry HK$2.50 · Close at T+365 HK$5.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wu Weiliang: trading record in brief
Wu Weiliang discloses dealings in China Regenerative Medicine International Ltd. to HKEX. Between 28 November 2019 and 29 December 2020, the trades on record add up to 9 filings.
Every open-market trade on record is a purchase: 8 purchases worth €4.1M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €59k and half below. Clusters matter here: 7 out of 8 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 25% of cases; the median change was -2.5%. These figures describe past trades and do not predict future prices.
On 11 January 2021 came the latest disclosure, a transaction in China Regenerative Medicine International Ltd. The latest purchase dates back some time: it was published 2,141 days ago, on 28 December 2020. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Wu Weiliang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,950,000 sharesShareXHKGHKEX:DA20210111E00237
- 48,330,000 shares@ HK$0.6985.4% of flowShareXHKGHKEX:DA20201228E00026Canonical exit: 24 Mar 2021 (T+90)
- 1,000,000 shares@ HK$0.250.7% of flowShareXHKGHKEX:DA20191211E00282Canonical exit: 10 Mar 2020 (T+90)
- 695,000 shares@ HK$0.240.5% of flowShareXHKGHKEX:DA20191209E00136Canonical exit: 5 Mar 2020 (T+90)
- 30,000 shares@ HK$0.23930.0% of flowShareXHKGHKEX:DA20191205E00357Canonical exit: 4 Mar 2020 (T+90)
- 1,795,000 shares@ HK$0.22291.1% of flowShareXHKGHKEX:DA20191204E00075Canonical exit: 2 Mar 2020 (T+90)
- 2,750,000 shares@ HK$0.22281.7% of flowShareXHKGHKEX:DA20191202E00260Canonical exit: 1 Mar 2020 (T+90)
- 8,500,000 shares@ HK$0.2235.3% of flowShareXHKGHKEX:DA20191129E00280Canonical exit: 27 Feb 2020 (T+90)
- 7,850,000 shares@ HK$0.24125.3% of flowShareXHKGHKEX:DA20191128E00350Canonical exit: 26 Feb 2020 (T+90)
9 of 9 declarations